Eric Hung
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Papers in ⓘ
- Toxicology 10
- Pharmacovigilance and Adverse Drug Reactions 10
-
- Drug-Induced Adverse Reactions 7
- Co-authors
- Manfred Hauben (14 shared papers)Jean‐Michel Dogné (2 shared papers)Lionel Van Holle (2 shared papers)F. Maignen (2 shared papers)Philip J. Mease (1 shared paper)Christina Charles‐Schoeman (1 shared paper)Cunshan Wang (1 shared paper)Ann Madsen (1 shared paper)
- Journals
- Pharmacoepidemiology and Drug Safety (4 papers)Therapeutic Advances in Drug Safety (3 papers)International Journal of Medical Sciences (1 paper)The Journal of Clinical Pharmacology (1 paper)Annals of the Rheumatic Diseases (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Eric Hung
15 papers receiving 330 citations
Peers
Comparison fields: 5 of 84
- Toxicology 108
- Rheumatology 94
- Internal Medicine 21
- Hematology 38
- Pharmacology 54
Countries citing papers authored by Eric Hung
This map shows the geographic impact of Eric Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Hung more than expected).
Fields of papers citing papers by Eric Hung
This network shows the impact of papers produced by Eric Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Hung. The network helps show where Eric Hung may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Hung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 153 | |
| 2 | 2013 | 40 | |
| 3 | 2016 | 23 | |
| 4 | 2013 | 20 | |
| 5 | 2017 | 18 | |
| 6 | 2021 | 16 | |
| 7 | 2016 | 14 | |
| 8 | 2022 | 14 | |
| 9 | 2013 | 9 | |
| 10 | 2013 | 9 | |
| 11 | 2020 | 6 | |
| 12 | 2015 | 5 | |
| 13 | 2021 | 4 | |
| 14 | 2016 | 3 | |
| 15 | 2024 | 1 |
About Eric Hung
Eric Hung is a scholar working on Toxicology, Pharmacology, Statistics and Probability, Internal Medicine and Pediatrics, Perinatology and Child Health, having authored 15 papers that have together received 335 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Drug-Induced Adverse Reactions (7 papers), Pharmaceutical studies and practices (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Statistical Methods in Clinical Trials (3 papers), Data-Driven Disease Surveillance (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Attention Deficit Hyperactivity Disorder (1 paper). The work is most often cited by research in Toxicology (108 citations), Rheumatology (94 citations), Internal Medicine (21 citations), Hematology (38 citations) and Pharmacology (54 citations). Eric Hung has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Manfred Hauben, Jean‐Michel Dogné, Lionel Van Holle, F. Maignen, Philip J. Mease, Christina Charles‐Schoeman, Cunshan Wang, Ann Madsen, Huifeng Yun and Joel M. Kremer. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Therapeutic Advances in Drug Safety, International Journal of Medical Sciences, The Journal of Clinical Pharmacology and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.